N. D’alessandro

发表

Correlation between expression of cyclooxygenase-2 and the presence of inflammatory cells in human primary hepatocellular carcinoma: possible role in tumor promotion and angiogenesis.

C. Tripodo, M. Soresi, A. Florena, 2005, World journal of gastroenterology.

From the covalent linkage of drugs to novel inhibitors of ribonucleotide reductase: synthesis and biological evaluation of valproic esters of 3'-C-methyladenosine.

R. Petrelli, L. Cappellacci, P. Kusumanchi, 2014, Bioorganic & medicinal chemistry letters.

Circulating IL‐6 and sIL‐6R in Patients with Hepatocellular Carcinoma

M. Soresi, M. Notarbartolo, M. Cervello, 2002, Annals of the New York Academy of Sciences.

NAIP-deltaEx10-11: a novel splice variant of the apoptosis inhibitor NAIP differently expressed in drug-sensitive and multidrug-resistant HL60 leukemia cells.

M. Notarbartolo, M. Cervello, N. D’alessandro, 2002, Leukemia research.

Epigenetic changes and nuclear factor-κB activation, but not microRNA-224, downregulate Raf-1 kinase inhibitor protein in triple-negative breast cancer SUM 159 cells.

P. Poma, M. Labbozzetta, M. Notarbartolo, 2015, Oncology letters.

Frequent alteration of the Yin Yang 1/Raf-1 kinase inhibitory protein ratio in hepatocellular carcinoma.

P. Poma, M. Labbozzetta, M. Notarbartolo, 2011, Omics : a journal of integrative biology.

Potentiation of the antitumor effects of both selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatic cancer cells by inhibition of the MEK/ERK pathway

M. Cervello, N. D’alessandro, G. Montalto, 2007, Cancer biology & therapy.

Influence of CYP 3 A 5 and ABCB 1 gene polymorphisms and other factors on tacrolimus dosing in Caucasian liver and kidney transplant patients

B. Gridelli, T. Bertani, P. Poma, 2022 .

Pharmacogenetic considerations for optimizing tacrolimus dosing in liver and kidney transplant patients.

C. Polidori, P. Poma, M. Labbozzetta, 2013, World journal of gastroenterology.

Sex Hormones and Risk of Liver Tumor

M. Soresi, M. Cervello, N. D’alessandro, 2006, Annals of the New York Academy of Sciences.

The use of proton pump inhibitors in an Italian hospital: focus on oncologic and critical non-ICU patients

M. Raffa, N. D’alessandro, M. Meli, 2015, International Journal of Clinical Pharmacy.

Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma.

M. Soresi, A. Florena, M. Cervello, 2006, World journal of gastroenterology.

Induction of Apoptosis and Inhibition of Cell Growth in Human Hepatocellular Carcinoma Cells by COX‐2 Inhibitors

P. Poma, M. Notarbartolo, M. Cervello, 2004, Annals of the New York Academy of Sciences.

Cyclooxygenase‐2 Expression in Chronic Liver Diseases and Hepatocellular Carcinoma

M. Soresi, A. Florena, E. Spada, 2009, Annals of the New York Academy of Sciences.

Heterocycle-containing retinoids. Discovery of a novel isoxazole arotinoid possessing potent apoptotic activity in multidrug and drug-induced apoptosis-resistant cells.

R. Baruchello, M. Roberti, N. D’alessandro, 2001, Journal of medicinal chemistry.

Induction of apoptosis by the proteasome inhibitor MG132 in human HCC cells: Possible correlation with specific caspase-dependent cleavage of beta-catenin and inhibition of beta-catenin-mediated transactivation.

P. Poma, M. Labbozzetta, M. Notarbartolo, 2004, International journal of molecular medicine.

517 Correlation of cyclooxygenase-2 expression with the presence of inflammatory cells in human primary hepatocellular carcinoma: A possible role in tumor promotion and angiogenesis

M. Notarbartolo, A. Florena, V. Franco, 2003 .

Prostaglandin E2 Receptors and COX Enzymes in Human Hepatocellular Carcinoma

M. Notarbartolo, M. Cervello, N. D’alessandro, 2009, Annals of the New York Academy of Sciences.

The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells.

C. Tripodo, M. Notarbartolo, A. Florena, 2006, International journal of molecular medicine.

Use of herbal remedies among cancer and transplant patients in the town of palermo, sicily

F. Fulfaro, N. D’alessandro, P. Polidori, 2010 .

Selective induction of apoptosis in multidrug resistant HL60R cells by the thiazolobenzoimidazole derivative 1-(2,6-difluorophenyl)-1H,3H-thiazolo [3,4-a] benzimidazole (TBZ).

N. D’alessandro, A. Chimirri, M. Tolomeo, 1998, European journal of cancer.

The antitumor activities of curcumin and of its isoxazole analogue are not affected by multiple gene expression changes in an MDR model of the MCF-7 breast cancer cell line: analysis of the possible molecular basis.

M. Rizzi, P. Poma, M. Labbozzetta, 2007, International journal of molecular medicine.

Induction of Apoptosis by the Adenosine Derivative IB-MECA in Parental or Multidrug-Resistant HL-60 Leukemia Cells: Possible Relationship to the Effects on Inhibitor of Apoptosis Protein Levels

P. Poma, M. Labbozzetta, M. Notarbartolo, 2005, Chemotherapy.

Resistance to diverse apoptotic triggers in multidrug resistant HL60 cells and its possible relationship to the expression of P-glycoprotein, Fas and of the novel anti-apoptosis factors IAP (inhibitory of apoptosis proteins).

M. Notarbartolo, M. Cervello, N. D’alessandro, 2002, Cancer letters.

Terapia farmacologica in odontoiatria pediatrica

G. Giuliana, N. D’alessandro, 2012 .

Combination chemotherapy with mitomycin C, vindesine and melphalan for refractory metastatic breast cancer

N. Gebbia, A. Russo, V. Gebbia, 2005, Journal of Cancer Research and Clinical Oncology.

Prostaglandin E 2 Receptors and COX Enzymes in Human Hepatocellular Carcinoma Role in the Regulation of Cell Growth

M. Notarbartolo, M. Cervello, N. D’alessandro, 2009 .

Lack of nucleophilic addition in the isoxazole and pyrazole diketone modified analogs of curcumin; implications for their antitumor and chemosensitizing activities.

R. Baruchello, P. Poma, M. Labbozzetta, 2009, Chemico-biological interactions.

Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression.

P. Poma, M. Notarbartolo, M. Cervello, 2005, Cancer letters.

Blocking signaling through the gp130 receptor chain by interleukin‐6 and oncostatin M inhibits PC‐3 cell growth and sensitizes the tumor cells to etoposide and cisplatin‐mediated cytotoxicity

G. Ciliberto, C. Toniatti, B. Bonavida, 1999, Cancer.

Structure-activity relationship studies of novel heteroretinoids: induction of apoptosis in the HL-60 cell line by a novel isoxazole-containing heteroretinoid.

N. D’alessandro, M. Tolomeo, E. Barbusca, 1999, Journal of medicinal chemistry.

Antitumor effects of curcumin and structurally beta-diketone modified analogs on multidrug resistant cancer cells.

M. Rizzi, R. Baruchello, P. Poma, 2008, Bioorganic & medicinal chemistry letters.

Cancer Therapy

H. Tapiero, N. D’alessandro, T. Tritton, 1993, NATO ASI Series.

Programmed cell death (PCD) associated with the stilbene motif of arotinoids: discovery of novel apoptosis inducer agents possessing activity on multidrug resistant tumor cells.

R. Baruchello, M. Roberti, N. D’alessandro, 2000, Bioorganic & medicinal chemistry letters.

Rash and multiorgan dysfunction following lamotrigine: could genetic be involved?

P. Poma, M. Labbozzetta, M. Notarbartolo, 2015, International Journal of Clinical Pharmacy.

Cytotoxic activity of the novel small molecule AKT inhibitor SC66 in hepatocellular carcinoma cells

J. McCubrey, M. Cervello, R. Puleio, 2014, Oncotarget.

The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis

N. D’alessandro, M. Tolomeo, M. Meli, 1998, Cell Death and Differentiation.

NF-κB Is a Potential Molecular Drug Target in Triple-Negative Breast Cancers.

P. Poma, M. Labbozzetta, M. Notarbartolo, 2017, Omics : a journal of integrative biology.

Curcumin as a Possible Lead Compound against Hormone‐Independent, Multidrug‐Resistant Breast Cancer

M. Rizzi, R. Baruchello, L. Inguglia, 2009, Annals of the New York Academy of Sciences.

Multifactorial nature of hepatocellular carcinoma drug resistance: could plant polyphenols be helpful?

P. Poma, N. D’alessandro, G. Montalto, 2007, World journal of gastroenterology.

Antitumor effects of the novel NF-kappaB inhibitor dehydroxymethyl-epoxyquinomicin on human hepatic cancer cells: analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production.

P. Poma, M. Labbozzetta, M. Notarbartolo, 2006, International journal of oncology.

Expression of IAPs and Alternative Splice Variants in Hepatocellular Carcinoma Tissues and Cells

P. Poma, M. Notarbartolo, M. Cervello, 2004, Annals of the New York Academy of Sciences.

Retinoic acid and analogs as potent inducers of differentiation and apoptosis. New promising chemopreventive and chemotherapeutic agents in oncology

R. Baruchello, M. Roberti, N. D’alessandro, 2001 .

Expression of WISPs and of Their Novel Alternative Variants in Human Hepatocellular Carcinoma Cells

M. Labbozzetta, M. Notarbartolo, M. Cervello, 2004, Annals of the New York Academy of Sciences.

In vivo effects of tumor necrosis factor‐α or flavone acetic acid in combination with doxorubicin on multidrug‐resistant B16 melanoma

N. Borsellino, N. D’alessandro, 1996, Anti-Cancer Drugs.

Timely Recognition of Cardiovascular Toxicity by Anticancer Agents: A Common Objective of the Pharmacologist, Oncologist and Cardiologist

S. Novo, N. D’alessandro, D. Di Lisi, 2012, Cardiovascular Toxicology.

High dose of trimethoprim-sulfamethoxazole and daptomycin as a therapeutic option for MRSA endocarditis with large vegetation complicated by embolic stroke: a case report and literature review.

P. Di Carlo, S. Novo, N. D’alessandro, 2013, Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive.

Resistance to gemcitabine in a lymphoma cell line resistant to Fas-mediated apoptosis.

M. Notarbartolo, N. D’alessandro, M. Tolomeo, 2004, Anticancer research.

Fluoroquinolone-induced liver injury: three new cases and a review of the literature

A. Craxì, N. D’alessandro, A. Licata, 2012, European Journal of Clinical Pharmacology.

Antitumor Effects of Dehydroxymethylepoxyquinomicin, a Novel Nuclear Factor-κB Inhibitor, in Human Liver Cancer Cells Are Mediated through a Reactive Oxygen Species-Dependent Mechanism

J. McCubrey, K. Umezawa, M. Cervello, 2009, Molecular Pharmacology.

Epigenetic agents as an adjunct to active chempotherapy in hematological tumor cell lines

R. Petrelli, L. Cappellacci, N. D’alessandro, 2012 .

BRONJ in patients with rheumatoid arthritis: a multicenter case series.

S. Fedele, A. Firenze, G. Campisi, 2016, Oral diseases.

Novel combination of Celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells

J. McCubrey, D. Bachvarov, J. Iovanna, 2010, Cell cycle.

Prevalence survey of healthcare-associated infections and antimicrobial use at the University Hospital "Paolo Giaccone", Palermo, Italy

N. D’alessandro, C. Mammina, M. V. Torregrossa, 2013, Journal of preventive medicine and hygiene.

Influence of CYP3A5 and ABCB1 gene polymorphisms and other factors on tacrolimus dosing in Caucasian liver and kidney transplant patients.

B. Gridelli, T. Bertani, P. Poma, 2011, International journal of molecular medicine.

Downregulation of wild-type beta-catenin expression by interleukin 6 in human hepatocarcinoma HepG2 cells: a possible role in the growth-regulatory effects of the cytokine?

M. Notarbartolo, M. Cervello, N. D’alessandro, 2001, European journal of cancer.

Expression of HIP/PAP mRNA in Human Hepatoma Cell Lines

J. Iovanna, M. Notarbartolo, M. Cervello, 2002, Annals of the New York Academy of Sciences.

The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in Caucasian liver transplant patients.

F. Triolo, B. Gridelli, P. Poma, 2009, Annals of transplantation.

Induction of apoptosis by arachidonic acid in human retinoblastoma Y79 cells: involvement of oxidative stress.

R. Vento, M. Giuliano, M. Lauricella, 2000, Experimental eye research.

Dexamethasone-induced cytotoxic activity and drug resistance effects in androgen-independent prostate tumor PC-3 cells are mediated by lipocortin 1.

N. D’alessandro, L. Parente, M. Carollo, 1998, Oncology research.

All trans retinoic acid sensitizes colon cancer cells to hyperthermia cytotoxic effects.

M. Libra, G. Emmanuele, S. Travali, 2003, International journal of oncology.

Analysis of possible mechanisms accounting for raf-1 kinase inhibitor protein downregulation in hepatocellular carcinoma.

P. Poma, M. Labbozzetta, M. Notarbartolo, 2012, Omics : a journal of integrative biology.

Expression of the IAPs in multidrug resistant tumor cells.

P. Poma, M. Notarbartolo, M. Cervello, 2004, Oncology reports.

Potential Therapeutic Applications of MDA-9/Syntenin-NF-κB-RKIP Loop in Human Liver Carcinoma.

P. Poma, M. Labbozzetta, M. Notarbartolo, 2019, Current molecular medicine.

Significance of Autologous Interleukin‐6 Production in the HA22T/VGH Cell Model of Hepatocellular Carcinoma

P. Poma, M. Labbozzetta, M. Notarbartolo, 2006, Annals of the New York Academy of Sciences.

NF-κB Is a Potential Molecular Drug Target in Triple-Negative Breast Cancers.

P. Poma, M. Labbozzetta, M. Notarbartolo, 2017, Omics : a journal of integrative biology.

NF-j B Is a Potential Molecular Drug Target in Triple-Negative Breast Cancers

P. Poma, M. Labbozzetta, M. Notarbartolo, 2017 .

Fluoroquinolone-induced liver injury: three new cases and a review of the literature

A. Craxì, N. D’alessandro, A. Licata, 2012, European Journal of Clinical Pharmacology.